Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Scanfil Q1'25: Share price has reached neutral zone

SCANFLResearch25.04.2025 klo 10.54
Antti ViljakainenHead of Research
Discuss
Download report (PDF)

Translation: Original published in Finnish on 4/25/2025 at 7:25 am EEST.

In our view, the overall picture of Scanfil's Q1 report published yesterday was rather neutral, and we did not make any changes to our forecasts following the report. In our view, the stock is reasonably valued (2025e: P/E 13x, EV/EBIT 10x), but the expected return no longer exceeds the sustainable required return on a 12-month horizon due to elevated macro risks. Hence, we reiterate our target price of EUR 9.00 on Scanfil and lower our recommendation to Reduce (previously Accumulate) as the stock's upside narrows. Our recent extensive report on Scanfil is available here.

Q1 impacted by ramp-up of new projects as expected

In Q1, Scanfil's revenue decreased by 3% to 193 MEUR from a reasonable comparison level. Organically, we estimate that revenue declined by about 7%, as the SRX acquisition supported revenue by around 4%, or 7.6 MEUR. The negative top-line development was mainly caused by sluggish demand, while the ramp-up of several new projects at various factories limited sales in the first months of the year, as previously communicated by the company. In Q1, Scanfil's adjusted EBITA decreased by around 4% to 12.6 MEUR. Profitability (adj. EBITA-%) remained at a satisfactory level for Scanfil at 6.5%, as the ramp-up of projects won last year also weakened the production efficiency of the factories in Q1. The company managed to sell 47 MEUR of new projects in Q1, which was about 5% higher than in the comparison period. We commented on Scanfil's Q1 figures in more detail on Thursday here. 

Guidance remained virtually unchanged

Scanfil updated its approach to guidance for the current year. The company now expects a revenue of 780-920 MEUR in 2025 (unchanged), and an adjusted EBITA of 55-68 MEUR (previously adj. EBIT 53-66 MEUR). In practice, however, the guidance remained unchanged, which was also in line with our expectations.

Due to a revision of the company's reporting and a change in the guidance, we moved the non-cash-flow-related PPA depreciation related to the acquisitions within non-recurring items as an adjustment item, but apart from this technical change, we did not make any changes to our estimates after the Q1 report. Our projections for the current year are in the lower half of the company's guidance ranges, as we expect the company's revenue to grow by 7% to 831 MEUR and adjusted EBITA by 9% to 60 MEUR this year. Over the next few years, we predict that Scanfil's adjusted EBIT will grow at a revenue-driven annual rate of around 5-10%. The main risks to our forecasts relate to external demand factors such as the global economy, while internally we believe the company is in relatively good shape. Given the company's reliance on local production, we do not expect Scanfil to be significantly impacted directly by tariffs, but due to the difficult-to-predict indirect effects, we also see a tightening of the trade political situation as a negative risk for Scanfil as well.

Pricing is starting to look pretty balanced on a one-year horizon

Based on our estimates for 2025 and 2026, Scanfil's adjusted P/E ratios are 13x and 12x, while the corresponding EV/EBITA ratios are 10x and 9x. We expect the dividend yields for the next few years to be around 3%. This year's multiples are in line with the company's moderate 5-year medians, and next year's multiples are below them. In relative terms, while Scanfil is atypically and uncharacteristically discount-priced, peer forecasts may not yet fully reflect the recent deterioration in the economic outlook and increase in risks. In our view, the stock as a whole is already quite correctly priced. Thus, the expected return is clearly positive, but it no longer exceeds the required return. Moreover, the stock's upside is already beginning to be limited when viewed against the DCF at our target price level.

Login required

This content is only available for logged in users

Create account

Scanfil is an international electronics contract manufacturer, specializing in industrial and B2B customers. Services include manufacturing of end products and components such as PCBs. Manufacturing services are the core of the company, supported by design, supply chain and modernization services. The company operates globally in Europe, America and Asia. Customers are primarily found in the process automation, energy efficiency, green efficiency and medical segments.

Read more on company page

Key Estimate Figures24.04.2025

202425e26e
Revenue779.9830.8876.1
growth-%-13.5 %6.5 %5.5 %
EBIT (adj.)54.959.863.8
EBIT-% (adj.)7.0 %7.2 %7.3 %
EPS (adj.)0.620.690.75
Dividend0.240.250.27
Dividend %2.9 %2.1 %2.3 %
P/E (adj.)13.317.115.7
EV/EBITDA7.69.68.9

Forum discussions

For Western companies selling to the Chinese market, local production is a competitive advantage that has become increasingly prominent in recent...
23 hours ago
by Pasi Hiedanpää
8
sttinfo.fi Scanfil laajentaa yhteistyötään Brukerin kanssa APAC-alueelle vastatakseen... Scanfil laajentaa yhteistyötään Brukerin Advanced X...
yesterday
by Cadel
12
Hanza, a peer company to Scanfil and Incap, published its Q3 results today, where revenue grew by 77% driven by acquisitions to SEK 2,487 million...
10/27/2026, 8:58 AM
by Tuukka Lundell
10
Antti and Tuukka have published a new company report on Scanfil following Q3 Scanfil’s Q3 figures published on Friday were operationally in ...
10/26/2026, 5:57 AM
by Sijoittaja-alokas
5
Here is Carnegie’s analysis on Scanfil following Q3 Scanfil’s Q3 report showed several encouraging signs for growth ahead, including: 1) organic...
10/24/2026, 1:15 PM
by Sijoittaja-alokas
5
Here are Antti’s and Tuukka’s quick comments on Scanfil’s Q3 results Scanfil released its Q3 report this morning. Driven by acquisitions, the...
10/23/2026, 6:26 AM
by Sijoittaja-alokas
8
And here are Scanfil’s Q3 key figures: July–September Revenue was EUR 252.2 million (191.3), an increase of 31.8% Revenue grew organically by...
10/23/2026, 5:03 AM
by Jukka
13